| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $135.0M | -6.9% |
| Cost of Revenue | $47.1M | -2.0% |
| Gross Profit | $87.9M | -9.3% |
| R&D Expense | $13.0M | -19.7% |
| SG&A Expense | $29.8M | -10.0% |
| Operating Income | $23.9M | +21.1% |
| Pre-tax Income | $27.6M | +7.2% |
| Income Tax | $4.6M | +72.6% |
| Net Income | $23.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $48.1M | +62.3% |
| Short-term Investments | $27.2M | -43.8% |
| Accounts Receivable | $76.6M | +19.6% |
| Inventory | $24.3M | -2.6% |
| Current Assets | $181.2M | +4.4% |
| Total Assets | $231.5M | -4.6% |
| Current Liabilities | $17.4M | -25.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $18.8M | -8.5% |
| Capital Expenditures | $1.3M | +2.5% |
| Investing Cash Flow | $34.0M | +317.1% |
| Financing Cash Flow | -$34.5M | +20.2% |
| Free Cash Flow | $17.4M | -9.3% |
| -0.4% |
| EPS (Basic) | $0.43 | +7.5% |
| EPS (Diluted) | $0.42 | +5.0% |
| Total Liabilities |
| $25.3M |
| -22.8% |
| Stockholders' Equity | $206.2M | -1.8% |